EdwinCKingsleyMD

Oncology • Las Vegas, NV

Physician

Join to view full profile

Dr. Kingsley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kingsley's full profile

Already have an account?

Office
3730 S Eastern Ave
Las Vegas, NV 89169
Phone+1 702-952-3400

Fax+1 702-952-3461

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1983 - 1985
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1980 - 1983
University of Utah School of MedicineClass of 1980

Certifications & Licensure

NV State Medical License 1985 - 2025
AZ State Medical License 1981 - 2020
UT State Medical License 1985 - 1986
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
Terminated
Phase 3
Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2014 Mar 13
Completed
Phase 1, Phase 2
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2018 Nov 01
Completed
Phase 3
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2017 Oct 04
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator
A Study of SGN-B6A in Advanced Solid Tumors Start of enrollment: 2020 Jun 08
Recruiting
Phase 1
Roles: Contact, Principal Investigator
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma Start of enrollment: 2022 Oct 27
Active, not recruiting
Phase 1
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
Linlin Xu, Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan Porter
Haematologica. 2024-07-01
11 citations
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.
Pier Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C De Oliveira
Journal of Clinical Oncology. 2023-11-20
2 citations
Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
Jorge J Castillo, Edwin C Kingsley, Mohit Narang, Habte A Yimer, Constantin A Dasanu
Ejhaem. 2023-02-01

Press Mentions

Introducing Vegas Inc’s 2021 Top DoctorsAugust 26th, 2021
Health Care Quarterly’s 2020 Top DoctorsAugust 20th, 2020
Top Doctors 2020August 1st, 2020
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member